Yondelis trabectedin regulatory update

The U.K.'s NICE issued a preliminary appraisal recommending against the use of Yondelis trabectedin from PharmaMar to treat advanced soft tissue sarcoma (STS). The cytotoxic alkaloid that binds the mi...